Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation

Mar.09
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
China Tobacco Hubei Industrial Co., Ltd. has published a patent describing a laboratory method to evaluate the reproductive and developmental safety of heated tobacco products using non-human animal exposure models. The approach introduces a structured toxicological testing framework that could support safety verification, quality control, and regulatory evidence generation for heated tobacco products.

Key Points

 

  • A new patent proposes an animal-based testing method to assess reproductive and developmental safety of heated tobacco exposure.
  • The method constructs controlled exposure models using Wistar rats and aerosol extracts from heated tobacco products.
  • Multiple indicators—including hormone levels, sperm quality, and offspring development—are used for safety evaluation.
  • The framework may help generate scientific evidence for product safety verification and regulatory submissions.

 

 

2Firsts, March 9, 2026

 

According to publicly available information on the patent database of China’s National Intellectual Property Administration (CNIPA), China Tobacco Hubei Industrial Co., Ltd., a subsidiary of China National Tobacco Corporation (CNTC), disclosed a patent titled “Method for Evaluating Reproductive and Developmental Safety Based on a Non-Human Animal Heated Cigarette Exposure Model.”

 

The patent application (No. 202511512948.X) was filed on October 22, 2025, and published on January 6, 2026 under publication number CN121275990A.

 

The invention outlines a structured experimental model designed to evaluate the potential reproductive and developmental effects of exposure to aerosols generated by heated tobacco products (HTPs).

 

Construction of a Heated Tobacco Exposure Model

 

The proposed method begins with the collection of aerosol particulate matter generated during the heating of tobacco sticks. These aerosols are condensed, dissolved, sterilized, and diluted to produce a smoke extract solution used for animal exposure experiments.

 

Researchers then construct non-human animal exposure models, typically using Wistar rats, which receive the aerosol extract via gavage over a defined exposure period. After exposure, animals are bred with untreated counterparts to observe potential reproductive outcomes.

 

This design allows researchers to simulate long-term exposure scenarios and evaluate whether aerosol constituents affect reproductive function or offspring development.

 

Multi-Dimensional Biological Indicators

 

The patent emphasizes the use of multiple biological indicators to evaluate reproductive and developmental safety.

 

Key measurements include:

 

Parental reproductive indicators

 

  • Testosterone synthesis and hormonal levels
  • Sperm density, motility, and morphology

 

Offspring developmental indicators

 

  • Litter size and sex ratio
  • Body weight and body length
  • Placental development metrics
  • Blood biochemical indicators such as endocrine and metabolic markers

 

These indicators allow researchers to assess both parental reproductive health and offspring developmental outcomes following heated tobacco exposure.

 

Experimental Benchmarking Against Reference Products

 

The patent describes comparative experiments using reference heated tobacco products considered “safety standard products,” including internationally marketed heated tobacco sticks.

 

Experimental groups exposed to aerosol extracts from different heated tobacco samples were compared with control groups receiving water. The reported results indicated no significant abnormalities in reproductive or developmental indicators, suggesting comparable outcomes across groups under the tested conditions.

 

Industry Implications

 

Safety evaluation remains a key issue in the regulatory landscape for next-generation nicotine products. While heated tobacco products typically generate fewer harmful constituents than combustible cigarettes, regulators continue to require toxicological and long-term health evidence before allowing market entry in many jurisdictions.

 

The method described in this patent illustrates how Chinese tobacco research institutions are developing structured preclinical testing frameworks for heated tobacco products. Such experimental models could support:

 

  • product safety validation
  • toxicological research
  • regulatory submissions in international markets
  • internal quality control during product development

 

As the global heated tobacco market expands and regulatory scrutiny intensifies, standardized evaluation methods may become increasingly important for both manufacturers and regulators.

 

More updates on the global next-generation nicotine industry are available at 2Firsts.

 

Cover Image source:CNIPA

Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-listed vape company iSpire Technology has restructured its leadership team, with Tuanfang Liu becoming the company’s sole chief executive officer (CEO) and Michael Wang appointed CEO of Aspire North America. The move ends iSpire’s previous co-CEO structure and creates clearer responsibilities between group strategy and regional execution. Separately, BTIG initiated coverage on iSpire Technology with a Buy rating and a $3.50 price target, identifying ODM growth opportunities as a key investment factor.
Jul.27
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
A former FDA toxicologist has questioned whether the agency fully assessed the material used in ZYN nicotine pouches before authorizing them for sale, raising concerns over possible microplastic exposure, according to STAT and The Examination.
Jul.16
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Russia, Ukraine and Belarus are tightening vape regulation through different tools, from Ukraine’s stronger enforcement push and Belarus’s proposed advertising restrictions to Russia’s new GOST standard and regional sales-ban mechanism. As black-market concerns persist, some Russian experts argue that China’s tightly controlled but legalised model — built around licensing, traceability and taxation — may offer a more effective alternative to blanket prohibition.
Jul.15
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
Malaysia Withdraws Appeal Against Liquid Nicotine Ruling as Vape Regulation Framework Enters New Phase
Malaysia Withdraws Appeal Against Liquid Nicotine Ruling as Vape Regulation Framework Enters New Phase
Malaysia’s government has withdrawn its appeal against a High Court ruling concerning the regulatory status of liquid nicotine used in vape and e-cigarette products, according to reports by New Straits Times, Free Malaysia Today and CodeBlue on August 18, 2026. The Kuala Lumpur High Court ruled on May 15 that the government’s decision to remove liquid nicotine from the scheduled poisons list under the Poisons Act 1952 was irrational and made without proper consultation with the Poisons Board. The withdrawal ends the government’s appeal process, while the future regulatory framework for nicotine vape products remains under discussion.
Aug.21